Medicare Enrolled
Dr. Uday Dandamudi, MD
Hematology · Trinity, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dandamudi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dandamudi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dandamudi
Dr. Uday Dandamudi is a hematology in Trinity, FL, with 19 years in practice. Based on federal Medicare data, Dr. Dandamudi performed 74,813 Medicare services across 2,352 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dandamudi received a total of $98,868 from 92 pharmaceutical and/or device companies across 1317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dandamudi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ 74,813 Medicare services$ $98,868 industry payments
Medicare Practice Summary
Medicare Utilization ↗74,813
Medicare services
Bottom 45% in FL for hematology
2,352
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,938 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 46,410 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 8,450 | $1 | $5 |
| Iron sucrose injection (Venofer) | 6,400 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 3,060 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $19 | $51 |
| Complete blood count (CBC) with differential | 1,424 | $8 | $29 |
| Blood draw (venipuncture) | 1,356 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,262 | $0 | $3 |
| Office visit, established patient (30-39 min) | 1,211 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 910 | $1 | $28 |
| Drug injection, under skin or into muscle | 430 | $10 | $69 |
| Injection of additional new drug or substance into vein | 286 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 276 | $96 | $378 |
| Red blood count automated, with additional calculations | 171 | $5 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 168 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 112 | $45 | $189 |
| Hospital follow-up visit, high complexity | 111 | $93 | $285 |
| Injection of drug or substance into vein | 104 | $28 | $156 |
| Office visit, established patient (20-29 min) | 90 | $59 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 75 | $21 | $84 |
| Infusion into a vein for hydration, each additional hour | 73 | $9 | $42 |
| Infusion, normal saline solution , 1000 cc | 72 | $2 | $7 |
| Administration of chemotherapy into vein, each additional hour | 64 | $22 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 64 | $1 | $3 |
| Hospital follow-up visit, moderate complexity | 60 | $62 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 59 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 56 | $15 | $56 |
| Initial hospital admission, high complexity | 56 | $135 | $556 |
| Administration of additional new drug or substance into vein, 1 hour or less | 50 | $49 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 44 | $25 | $89 |
| New patient office visit (45-59 min) | 43 | $110 | $453 |
| Infusion into a vein for hydration, 31-60 minutes | 39 | $23 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $16 | $59 |
| Automated urinalysis | 22 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 21 | $167 | $585 |
| Initial hospital admission, moderate complexity | 16 | $103 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
62.6% high complexity
31.2% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$98,868
Total received (2018-2024)
Avg $14,124/year across 7 years
Top 4% in FL for hematology
92
Companies
1,317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,626 (44.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,025 (37.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,217 (18.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$13,213
2023$12,441
2022$16,029
2021$3,531
2020$5,263
2019$5,759
2018$42,633
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$39,095
AstraZeneca Pharmaceuticals LP
$7,883
Incyte Corporation
$7,063
Gilead Sciences, Inc.
$4,822
Takeda Pharmaceuticals U.S.A., Inc.
$4,116
Exelixis Inc.
$3,759
Eisai Inc.
$3,693
Bayer HealthCare Pharmaceuticals Inc.
$3,670
Deciphera Pharmaceuticals Inc.
$3,481
Janssen Biotech, Inc.
$2,375
Novartis Pharmaceuticals Corporation
$1,754
Celgene Corporation
$1,436
CTI BioPharma Corp.
$1,266
EISAI INC.
$1,146
BeiGene USA, Inc.
$898
Genentech USA, Inc.
$858
PFIZER INC.
$844
Daiichi Sankyo Inc.
$812
GENZYME CORPORATION
$800
Janssen Scientific Affairs, LLC
$758
Amgen Inc.
$617
GlaxoSmithKline, LLC.
$616
Lilly USA, LLC
$542
Merck Sharp & Dohme Corporation
$483
Merck Sharp & Dohme LLC
$439
Seagen Inc.
$364
Alexion Pharmaceuticals, Inc.
$332
Kite Pharma, Inc.
$280
Myriad Genetic Laboratories, Inc.
$263
Regeneron Healthcare Solutions, Inc.
$226
SOBI, INC
$218
AbbVie Inc.
$212
Astellas Pharma US Inc
$210
Mirati Therapeutics, Inc.
$192
ABBVIE INC.
$188
Ipsen Biopharmaceuticals, Inc
$184
PUMA BIOTECHNOLOGY, INC.
$168
JAZZ PHARMACEUTICALS INC.
$162
EMD Serono, Inc.
$140
ARRAY BIOPHARMA INC
$139
Agios Pharmaceuticals, Inc.
$111
Bayer Healthcare Pharmaceuticals Inc.
$109
Seattle Genetics, Inc.
$98
Pharmacyclics LLC, An AbbVie Company
$97
TESARO, Inc.
$95
AbbVie, Inc.
$91
TAIHO ONCOLOGY, INC.
$79
Pharmacosmos Therapeutics Inc.
$76
MorphoSys, US Inc.
$75
PORTOLA PHARMACEUTICALS, INC.
$74
TerSera Therapeutics LLC
$73
Karyopharm Therapeutics Inc.
$70
SERVIER PHARMACEUTICALS LLC
$68
Tempus AI, Inc
$67
Janssen Products, LP
$65
Fennec Pharmaceuticals, Inc.
$65
Array BioPharma Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Medtronic, Inc.
$51
Kyowa Kirin, Inc.
$48
Epizyme, Inc.,
$47
Stemline Therapeutics Inc.
$44
Jazz Pharmaceuticals Inc.
$42
Blueprint Medicines Corporation
$42
MEDIVATION FIELD SOLUTIONS LLC
$41
Puma Biotechnology, Inc.
$41
Foundation Medicine, Inc.
$38
GE HealthCare
$37
Dendreon Pharmaceuticals LLC
$36
AVEO Pharmaceuticals, Inc.
$35
Servier Pharmaceuticals LLC
$33
Clovis Oncology, Inc.
$30
Myovant Sciences Inc.
$30
Pharmacyclics LLC, an AbbVie Company
$26
Janssen Pharmaceuticals, Inc
$25
SpringWorks Therapeutics, Inc.
$25
Adaptive Biotechnologies Corporation
$24
CSL Behring
$20
Genmab U.S., Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
ImmunoGen, Inc.
$18
Ethicon US, LLC
$18
Acrotech Biopharma Inc.
$18
G1 Therapeutics, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Lantheus Medical Imaging, Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Sumitomo Pharma America, Inc.
$14
Aurobindo Pharma USA, Inc.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 54.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ANORO · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BEVYXXA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · COSELA · CYMBALTA · CYRAMZA · Cabometyx · Cotellic · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · PreciseTumor · Prolia · QINLOCK · Quadramet · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TRELEGY ELLIPTA · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XERMELO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (44%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for hematology in FL.
Equivalent to $132 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
41
Per 100K population
7.0
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dandamudi is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dandamudi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dandamudi performed 46,410 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dandamudi receive payments from pharmaceutical companies?
Yes. Dr. Dandamudi received a total of $98,868 from 92 companies across 1,317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dandamudi's costs compare to other hematologys in Trinity?
Dr. Dandamudi's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dandamudi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Trinity
Browse hematologys in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology